Exercise Support and Rehabilitation for Patients After Spontaneous Coronary Artery Dissection
Launched by UNIVERSITY OF LEICESTER · Apr 24, 2025
Trial Information
Current as of August 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a remote exercise program can help women recover after experiencing a spontaneous coronary artery dissection (SCAD), which is a type of heart attack that mainly affects otherwise healthy women. The study aims to see if this kind of exercise program can be successfully done at home, as traditional cardiac rehab programs are often designed for older patients and may not be suitable for younger women recovering from SCAD.
To be eligible for this trial, participants need to be women aged 18 or older who have been diagnosed with SCAD and referred to the Leicester SCAD clinic. They should also have a good heart function and be able to travel to the clinic for appointments. Unfortunately, those without access to a smartphone or the internet, or who cannot understand explanations in English, won't be able to participate. If you join the trial, you can expect to take part in exercise sessions that are tailored to your recovery needs, all while being supported remotely.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female
- • Aged ≥18 years.
- • Diagnosed with angiographically confirmed SCAD and referred to the Leicester SCAD clinic.
- • Ejection fraction \>45%.
- • Blood pressure \<180/100. Resting heart rate \<100bpm
- Exclusion Criteria:
- • No SCAD diagnosis.
- • Unable to travel to Leicester Hospital for their SCAD clinic appointment.
- • Unable to give informed consent.
- • No smart phone or internet access
- • Unable to understand verbal explanations in English.
About University Of Leicester
The University of Leicester is a leading research institution in the UK, renowned for its commitment to advancing scientific knowledge and improving healthcare through innovative clinical trials. The university fosters a collaborative environment that integrates diverse disciplines, enabling the development of cutting-edge research initiatives aimed at addressing pressing medical challenges. With a focus on ethical practices and patient-centered outcomes, the University of Leicester is dedicated to enhancing clinical research methodologies and contributing to the advancement of medical sciences, ultimately striving to translate research findings into tangible health benefits for communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leicester, Leicestershire, United Kingdom
Patients applied
Trial Officials
David Adlam, BA BM BCh DPhil FRCP FESC
Principal Investigator
University of Leicester
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported